Sleepy Hollow, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP, founded in 2010, is a small nonprofit in the Medical Research sector that reported $378K in total revenue in fiscal year 2024. Revenue surged 130% from the prior year, signaling strong growth momentum. The organization ran a surplus of $148K, a strong 39% operating margin.
The mission of ITMIG is to promote the advancement of clinical and basic science pertaining to thymic and other mediastinal malignancies and related conditions
ITMIG is aligned with the Foundation for Thymic Cancer Research to advance program services through coordination of the executive director.
The ITMIG database is a major resource for studying the characteristics, treatment strategies, and outcomes of patients with thymic malignancies. More than 2000 patients are enrolled. The database is...
The ITMIG database is a major resource for studying the characteristics, treatment strategies, and outcomes of patients with thymic malignancies. More than 2000 patients are enrolled. The database is open to all researches and has data transfer agreements with all major institutions.
The 2024 Annual Meeting was held in Yokohama, Japan, in collaboration with the Japan Lung Cancer Society. The abstract book from the meeting is available in MEDIASTINUM.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $377,806 | $164,486 | +1.3% |
| Expenses | $229,580 | $138,896 | +0.7% |
| Net Income | $148,226 | $25,590 | +4.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Pam Bruce | Director | 40.00 |
Key Emp
|
$0 | $0 | $0 |
| Dr Malgorzata Szolkowska | President | 25.00 |
Director
|
$0 | $0 | $0 |
| Dr Paolo Mendogni | Secretary | 25.00 |
Director
|
$0 | $0 | $0 |
| Dr Annemarie Fernandes Shepherd | Treasurer | 25.00 |
Director
|
$0 | $0 | $0 |
| Dr Dirk Van Raemdonck | Vjce President | 25.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2025 | No data | No data | No data | No data |
| 2024 | $377,806 | $229,580 | $316,149 | $148,226 |
| 2024 | $373,790 | $229,580 | $312,142 | $144,210 |
Compare INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP with other nonprofits in New York and across the country.